Incendia Therapeutics Announces Upcoming Presentations at the American Association for Cancer Research 2024 : vimarsana.com

CAMBRIDGE, Mass., April 05, 2024--Incendia Therapeutics, a precision oncology company discovering and developing a novel class of therapies that reprogram the tumor microenvironment (TME), today announced that it will have three poster presentations at the American Association for Cancer Research (AACR) Annual Meeting 2024, taking place April 5-10, 2024 in San Diego, California.

Related Keywords

Cambridge , Cambridgeshire , United Kingdom , San Diego , California , United States , American , Yanchao Wang , Bonnie Phillips , Laura Dillon , Linkedin , American Association For Cancer Research , Development At Alpenglow Biosciences , Incendia Therapeutics , American Association , Cancer Research , Annual Meeting , Vice President , Translational Medicine , Discoidin Domain Receptor , Tumor Microenvironment , Immune Exclusion Scores , Data Scientist , Artificial Intelligence , Deep Learning , Alpenglow Biosciences , Commercial Development , Liquid Biopsy , Pithelial Tumor , Acr , Immune Cells , Protein Expression , Pithelial Tumors , Abstract Number , Exclusion ,